<?xml version="1.0" encoding="UTF-8"?>
<p>The rapid spread of SARS-CoV-2 demands the immediate development of effective and safe therapeutic strategies. In the absence of licensed vaccines and approved antiviral drugs, the most promising approach adopted by researchers is the repurposing of drugs [
 <xref rid="B12-pathogens-09-00519" ref-type="bibr">12</xref>,
 <xref rid="B124-pathogens-09-00519" ref-type="bibr">124</xref>]. However, no specific anti-SARS-CoV-2 treatment has been recommended by the US FDA, yet owing to the lack of supportive data.
</p>
